Q4
Q4 Inc. (“Q4” or “the company”), the IR Ops Platform, today announced it is a winner in the 2024 International Business Awards®. Honored for its “effectiveness in supporting client needs,” the company’s Web Content Services (WCS) team earned a bronze Stevie® Award for “Customer Service Team of the Year” — a category that spanned across industries — underscoring Q4’s commitment to delivering outstanding customer experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240819909828/en/
IBA Bronze Stevie Winner Badge (Graphic: Business Wire)
This is the second year in a row Q4 has been honored in the International Business Awards.
Considered “the Olympics for the workplace,” the International Business Awards (IBAs) are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small — are eligible to submit nominations. The 2024 IBAs received entries from organizations in 62 nations and territories, with more than 3,600 nominations submitted.
Here’s what the judges had to say about Q4’s WCS team:
- “Their achievements reflect exceptional efficiency, accuracy, and client satisfaction.”
- “The team’s ability to handle client requests efficiently, maintain high accuracy, and achieve record CSAT scores highlights their effectiveness in supporting client needs.”
- “Q4’s core company values shine through in the way this team operates.”
- Q4’s WCS team shows “exceptional performance in customer service through impressive metrics, continuous improvement, and a commitment to customer satisfaction.”
- “The WCS team at Q4 has demonstrated outstanding performance.”
“IROs and their teams have a lot on their plates, and we want to alleviate that burden through our AI-driven IR Ops Platform,” said Darrell Heaps, Founder and CEO of Q4. “This recognition from the International Business Awards shows how our amazing Web Content Services team does just that. It also highlights the high-impact results our customers achieve — using Q4 to build investor relationships and make strategic decisions. As we continue to chart a bold, new path for investor relations, we’re committed to innovation that helps IR teams realize remarkable outcomes and frees up their time to focus on what matters: strategy, relationships, and driving premium valuations for their companies.”
Q4: A single, powerful platform for investor relations
Public companies today strive to maintain up-to-date, secure and compliant investor relations websites — so they can demonstrate what they do, attract investors, and motivate them to take action. Q4’s technology makes it easy for some of the world’s biggest brands — McDonald’s, Walmart, Visa, Netflix and many more — to create and manage IR websites that drive results, accelerate website updates (publishing changes within minutes, and 16 times faster than with other tools), streamline earnings management, and tap into real-time analytics on investor behavior. With decades of website design and IR experience, Q4’s award-winning WCS team provides further assistance with website development and change requests, as well as Q4 Platform support.
Websites are just one component of Q4’s holistic IR Ops Platform, an unprecedented and unified system for attracting investors, managing relationships and staying abreast of the market’s pulse. Rather than grapple with disparate and disconnected tools, IR leaders and their companies can access everything they need from a single place: using Q4 for IR websites, virtual events, an IR CRM, surveillance, engagement analytics and more, including secure AI for IR.
Q4’s win in the International Business Awards comes on the heels of other recent milestones and momentum for the company. Q4 has powered more than 18 million investor interactions and hosts 4,400 events annually — with 530,000+ investors connecting to events via the Q4 Platform each month. Named “Best Tech-Driven Capital Markets Platform” by Global Brands Magazine, Q4 serves more than 2,600 global clients, including half of the S&P 500.
About Q4 Inc.
Q4 Inc. is the first IR Ops Platform with the world’s largest set of proprietary investor data, purpose-built to remove obstacles between public companies and their investors. Q4 gives investor relations leaders and their teams the tools to attract, manage, and understand investors — all in one place. The AI-enabled Q4 IR Ops Platform boasts applications for website and event management, engagement analytics, and earnings lifecycle management, including AI Earnings Co-Pilot to generate draft scripts based on historical data, and AI earnings call summaries to understand peer sentiment. The Platform also includes a streamlined investor CRM and shareholder intelligence with enhanced metrics to elevate investor targeting strategies. Q4 delivers the data, insights, and workflows that give IR teams the power to focus on what really matters: strategy, relationships, and driving premium valuations for their companies.
The company is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world, and maintains an award winning culture where team members grow and thrive.
Q4 is headquartered in Toronto, with offices in London and Copenhagen. Learn more at www.q4inc.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240819909828/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom